Artelo Biosciences Stock Price Patterns
| ARTL Stock | USD 1.71 0.03 1.79% |
Momentum 56
Buy Extended
Oversold | Overbought |
EPS Estimate Next Quarter (1.57) | EPS Estimate Current Year (12.11) | EPS Estimate Next Year (3.28) | Wall Street Target Price 18 | EPS Estimate Current Quarter (0.82) |
Using Artelo Biosciences hype-based prediction, you can estimate the value of Artelo Biosciences from the perspective of Artelo Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Artelo Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Artelo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Artelo Biosciences after-hype prediction price | USD 1.71 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Artelo Biosciences Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Artelo Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Artelo Biosciences After-Hype Price Density Analysis
As far as predicting the price of Artelo Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Artelo Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Artelo Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Artelo Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Artelo Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Artelo Biosciences' historical news coverage. Artelo Biosciences' after-hype downside and upside margins for the prediction period are 0.09 and 8.52, respectively. We have considered Artelo Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Artelo Biosciences is extremely dangerous at this time. Analysis and calculation of next after-hype price of Artelo Biosciences is based on 3 months time horizon.
Artelo Biosciences Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Artelo Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Artelo Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Artelo Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.08 | 6.81 | 0.22 | 0.00 | 7 Events / Month | 5 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.71 | 1.71 | 0.00 |
|
Artelo Biosciences Hype Timeline
Artelo Biosciences is presently traded for 1.71. The entity has historical hype elasticity of -0.22, and average elasticity to hype of competition of 0.0. Artelo is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at 0.08%. %. The volatility of related hype on Artelo Biosciences is about 24496.4%, with the expected price after the next announcement by competition of 1.71. The company has price-to-book (P/B) ratio of 0.5. Some equities with similar Price to Book (P/B) outperform the market in the long run. Artelo Biosciences recorded a loss per share of 19.5. The entity last dividend was issued on the 21st of June 2019. The firm had 1:6 split on the 13th of June 2025. Given the investment horizon of 90 days the next anticipated press release will be in about 7 days. Check out Artelo Biosciences Basic Forecasting Models to cross-verify your projections.Artelo Biosciences Related Hype Analysis
Having access to credible news sources related to Artelo Biosciences' direct competition is more important than ever and may enhance your ability to predict Artelo Biosciences' future price movements. Getting to know how Artelo Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Artelo Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GTBP | GT Biopharma | 0.03 | 9 per month | 0.00 | (0.02) | 10.84 | (11.96) | 51.03 | |
| PTIX | Protagenic Therapeutics | 0.17 | 3 per month | 0.00 | (0.21) | 14.81 | (15.25) | 58.73 | |
| CARM | Carisma Therapeutics | 0 | 5 per month | 9.24 | 0 | 18.00 | (14.06) | 56.42 | |
| SLRX | Salarius Pharmaceuticals | (0.02) | 6 per month | 0.00 | (0.19) | 16.00 | (16.92) | 61.05 | |
| PBM | Psyence Biomedical Ltd | 0.03 | 9 per month | 14.50 | 0.07 | 12.65 | (13.79) | 96.66 | |
| REVB | Revelation Biosciences | 0.08 | 7 per month | 0.00 | (0.24) | 6.12 | (9.09) | 35.57 | |
| LIPO | Lipella Pharmaceuticals Common | 0.00 | 0 per month | 0.00 | (0.02) | 17.14 | (16.00) | 44.95 | |
| SPRC | Scisparc | (0.01) | 7 per month | 0.00 | (0.41) | 3.57 | (12.20) | 30.69 | |
| SLXN | Biomotion Sciences Ordinary | (0.56) | 3 per month | 0.00 | (0.13) | 15.09 | (8.19) | 37.24 | |
| WINT | Windtree Therapeutics | 0.00 | 6 per month | 0.00 | (0.24) | 16.67 | (20.00) | 58.33 |
Artelo Biosciences Additional Predictive Modules
Most predictive techniques to examine Artelo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Artelo using various technical indicators. When you analyze Artelo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Artelo Biosciences Predictive Indicators
The successful prediction of Artelo Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Artelo Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Artelo Biosciences based on analysis of Artelo Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Artelo Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Artelo Biosciences's related companies. | 2024 | 2025 | 2026 (projected) | Net Debt To EBITDA | 0.22 | 0.25 | 0.24 | Intangibles To Total Assets | 0.43 | 0.5 | 0.3 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Artelo Biosciences Basic Forecasting Models to cross-verify your projections. For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Artelo Biosciences. If investors know Artelo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Artelo Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Artelo Biosciences is measured differently than its book value, which is the value of Artelo that is recorded on the company's balance sheet. Investors also form their own opinion of Artelo Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Artelo Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Artelo Biosciences' market value can be influenced by many factors that don't directly affect Artelo Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Artelo Biosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Artelo Biosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Artelo Biosciences' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.